tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CADL Stock Latest News

Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Press ReleasesCandel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
1M ago
CADL
Candel Therapeutics reports Q2 EPS (74c) vs (33c) last year
PremiumThe Fly
Candel Therapeutics reports Q2 EPS (74c) vs (33c) last year
1M ago
CADL
Candel Therapeutics to join Russell 3000 Index
PremiumThe Fly
Candel Therapeutics to join Russell 3000 Index
3M ago
CADL
Candel Therapeutics to Join Russell 3000® Index
PremiumPress Releases
Candel Therapeutics to Join Russell 3000® Index
3M ago
CADL
Candel Therapeutics receives Orphan Drug Designation for CAN-3110
PremiumThe Fly
Candel Therapeutics receives Orphan Drug Designation for CAN-3110
4M ago
CADL
Candel Therapeutics up 49% after Phase 2 CAN-2409 update ahead of ASCO
PremiumThe FlyCandel Therapeutics up 49% after Phase 2 CAN-2409 update ahead of ASCO
4M ago
CADL
Candel Therapeutics presents Phase 2 data on CAN-2409 for NSCLC at ASCO
Premium
The Fly
Candel Therapeutics presents Phase 2 data on CAN-2409 for NSCLC at ASCO
4M ago
CADL
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting
Premium
Press Releases
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting
4M ago
CADL
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
PremiumPress Releases
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
4M ago
CADL
Candel Therapeutics reports Q1 EPS (28c) vs (30c) last year
PremiumThe Fly
Candel Therapeutics reports Q1 EPS (28c) vs (30c) last year
4M ago
CADL
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4M ago
CADL
Candel Therapeutics to Present Promising Cancer Trial Data
PremiumCompany Announcements
Candel Therapeutics to Present Promising Cancer Trial Data
5M ago
8K
CADL
Candel Therapeutics to present on CAN-3110, CAN-2409 at ASCO meeting
PremiumThe FlyCandel Therapeutics to present on CAN-3110, CAN-2409 at ASCO meeting
5M ago
CADL
Three new option listings on April 15th
Premium
The Fly
Three new option listings on April 15th
5M ago
CADL
DXYZ
Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment
Premium
Company Announcements
Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment
5M ago
8K
CADL
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
PremiumPress Releases
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
5M ago
CADL
Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409
PremiumThe Fly
Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409
5M ago
CADL
Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate
PremiumCompany Announcements
Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate
5M ago
8K
CADL
Candel Therapeutics presents preclinical data on immunotherapy candidate
PremiumThe Fly
Candel Therapeutics presents preclinical data on immunotherapy candidate
5M ago
CADL
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
PremiumPress ReleasesCandel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
5M ago
CADL
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
Premium
The Fly
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
6M ago
CADL
Candel Therapeutics Inc trading resumes
Premium
The Fly
Candel Therapeutics Inc trading resumes
6M ago
CADL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >